Does SECUKINUMAB Cause Deafness neurosensory? 11 Reports in FDA Database
Visibly Younger Skin in Weeks
Synevra Lift & Lock — Swiss peptide serum + nutrients. 60-day money-back guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 11 reports of Deafness neurosensory have been filed in association with SECUKINUMAB (COSENTYX). This represents 0.0% of all adverse event reports for SECUKINUMAB.
11
Reports of Deafness neurosensory with SECUKINUMAB
0.0%
of all SECUKINUMAB reports
0
Deaths
5
Hospitalizations
How Dangerous Is Deafness neurosensory From SECUKINUMAB?
Of the 11 reports, 5 (45.5%) required hospitalization, and 1 (9.1%) were considered life-threatening.
Is Deafness neurosensory Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for SECUKINUMAB. However, 11 reports have been filed with the FAERS database.
What Other Side Effects Does SECUKINUMAB Cause?
Drug ineffective (27,434)
Psoriasis (21,976)
Pain (15,244)
Arthralgia (13,769)
Fatigue (9,406)
Psoriatic arthropathy (8,900)
Pruritus (8,755)
Malaise (8,570)
Rash (8,023)
Condition aggravated (7,536)
What Other Drugs Cause Deafness neurosensory?
METHOTREXATE (224)
FENTANYL (202)
OXYCODONE (198)
ETANERCEPT (171)
TEPROTUMUMAB-TRBW (171)
TOCILIZUMAB (164)
HYDROXYCHLOROQUINE (162)
SULFASALAZINE (153)
ABATACEPT (149)
CELECOXIB (143)
Which SECUKINUMAB Alternatives Have Lower Deafness neurosensory Risk?
SECUKINUMAB vs SELADELPAR LYSINE
SECUKINUMAB vs SELEGILINE
SECUKINUMAB vs SELENIUM
SECUKINUMAB vs SELENIUM SULFIDE
SECUKINUMAB vs SELEXIPAG